Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Retinol may affect immune responses in people with frequent skin boils.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Skin and mucous symptoms are key for diagnosing autoimmune connective tissue diseases.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Hidradenitis suppurativa is linked to autoinflammation and immune system issues.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Upadacitinib improved multiple immune-related conditions in one patient.

A 13-year-old girl with various symptoms was successfully treated with an antibiotic called co-trimoxazole.

Children with different rheumatologic diseases have specific skin symptoms that can help with diagnosis.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Depression and skin autoimmune diseases are linked, needing combined care for better treatment.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

The document concludes that corticosteroids effectively treat vasculitis allergica in over 90% of cases, with long-term kidney issues being the main adverse outcome.

People with primary immunodeficiencies often have frequent, severe, or unusual infections and may need special tests and management strategies.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

TNF-inhibitor induced alopecia can be treated effectively with different therapies.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Anti-TNF therapy can cause hair loss and skin issues.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

Volatile organic compounds can cause inflammation and increase the risk of autoimmune diseases.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

Chronic skin diseases and metabolic syndrome are linked by shared inflammation pathways.